Shares of Fresenius Medical Care AG (ETR:FME - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €46.12 ($54.26) and traded as high as €48.09 ($56.58). Fresenius Medical Care shares last traded at €47.88 ($56.33), with a volume of 400,299 shares trading hands.
Fresenius Medical Care Stock Up 0.4%
The company has a market cap of $14.17 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 0.42 and a beta of 0.86. The company has a current ratio of 1.37, a quick ratio of 0.80 and a debt-to-equity ratio of 82.24. The business has a fifty day moving average of €49.19 and a two-hundred day moving average of €46.17.
Fresenius Medical Care Company Profile
(
Get Free Report)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Recommended Stories
Before you consider Fresenius Medical Care, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.
While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
